Skip to main content
PMC home page
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1985 Aug;20(1):6–10. doi: 10.1007/BF00199766

Tumour necrosis factor and the lysosomal enzymes of macrophages or macrophage-like cell line

Akiko Sakurai 1,✉, Nobuko Satomi 1, Katsuyuki Haranaka 1
PMCID: PMC11038792  PMID: 3851696

Abstract

The relationship between tumour necrosis factor (TNF) and macrophages or macrophage-like cell line, especially the lysosomal enzymes was investigated. The serum lysosomal enzymes and LDH activities were increased in proportion to the TNF production even in different strains of mice. Lysosomal enzymes and TNF activity were released into the supernatant of the culture medium of macrophage-enriched peritoneal exudate cells (PEC) or spleen cells derived from Propionibacterium acnes-primed mice after addition of lipopolysaccharide (LPS). After passage through a Sephadex G-10 column, TNF activity could not be detected in the supernatant of these spleen cells after addition of LPS. Also TNF activity could not be detected in the supernatant following destruction of PEC. These results suggest that TNF producibility is strongly related to the degree of activation of macrophages, especially the lysosomal enzymes. The murine macrophage-like cell line, J 774, also released TNF activity and lysosomal enzymes after addition of LPS.

Keywords: Cancer Research, Tumour Necrosis, Tumour Necrosis Factor, Spleen Cell, Lysosomal Enzyme

References

  • 1.Bergmeyer HU, Bernt Z. Methods of Enzymatic Analysis. New York: Academic Press; 1974. Lactate dehydrogenase; p. 574. [Google Scholar]
  • 2.Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA. 1975;72:3666. doi: 10.1073/pnas.72.9.3666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Cummins CS, Stimpson SA, Tuttle RL, Weck CJ. Observation on the nature of the determinants in anaerobic Coryneforms which produce splenomegaly. J Reticuloendothel Soc. 1981;29:1. [PubMed] [Google Scholar]
  • 4.Haranaka K, Satomi N. Cytotoxic activity of tumor necrosis factor (TNF) on human cancer cells in vitro . Jpn J Exp Med. 1981;51:191. [PubMed] [Google Scholar]
  • 5.Haranaka K, Satomi N, Sakurai A. Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice. Int J Cancer. 1984;34:263. doi: 10.1002/ijc.2910340219. [DOI] [PubMed] [Google Scholar]
  • 6.Haranaka K, Satomi N, Sakurai A. Differences in tumor necrosis factor productive ability among rodents. Br J Cancer. 1984;50:471. doi: 10.1038/bjc.1984.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Haranaka K, Satomi N, Sakurai A, Haranaka R. Role of first stimulating agents in the production of tumor necrosis factor. Cancer Immunol Immunother. 1984;18:87. doi: 10.1007/BF00205740. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Helson L, Green S, Carswell EA, Old LJ. Effect of tumor necrosis factor on cultured human melanoma cells. Nature. 1975;258:731. doi: 10.1038/258731a0. [DOI] [PubMed] [Google Scholar]
  • 9.Helson L, Helson C, Green S. Effects of murine tumor necrosis factor on heterotransplanted human tumors. Exp Cell Biol. 1979;47:53. doi: 10.1159/000162922. [DOI] [PubMed] [Google Scholar]
  • 10.Kato K, Yoshida K, Tsukamoto H, Nobunaga M, Masuya T, Sawada T. β-D-Glucopyranosiduronic acid and its utilization as a substrate for the assay of β-glucuronidase activity. Chem Pharm Bull. 1960;8:239. [Google Scholar]
  • 11.Kind PRN, King EJ. Estimation of plasma phosphatase by determination of hydrolysed phenol with amino-antipyrine. J Clin Path. 1954;7:322. doi: 10.1136/jcp.7.4.322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Männel N, Moore RN, Mergenhagen SE. Macrophages as a source of tumoricidal activity (tumor necrotizing factor) Infect Immun. 1980;30:523. doi: 10.1128/iai.30.2.523-530.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Matthews N, Watkins JF. Tumor-necrosis factor from the rabbit. I. Mode of action, specificity and physicochemical properties. Br J Cancer. 1978;38:302. doi: 10.1038/bjc.1978.202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Old LJ. Tumor necrosis factor. Clin Bull. 1976;6:118. [PubMed] [Google Scholar]
  • 15.Satomi N, Haranaka K, Kunii O. Research on the production site of tumor necrosis factor. Jpn J Exp Med. 1981;51:317. [PubMed] [Google Scholar]
  • 16.Sawiki JE, Catanzaro RJ. Selective macrophage cytotoxicity of carrageenan in vivo . Int Arch Allergy Appl Immun. 1975;49:709. doi: 10.1159/000231451. [DOI] [PubMed] [Google Scholar]
  • 17.Schnyder J, Boggiolini M. Secretion of lysosomal hydrolases by stimulated and nonstimulated macrophages. J Exp Med. 1978;148:435. doi: 10.1084/jem.148.2.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Suter E, Ullman GE, Hoffman RG. Sensitivity of mice to endotoxin after vaccination with B.C.G. (Bacillus Calmette-Güerin) Proc Soc Exp Biol Med. 1958;99:167. doi: 10.3181/00379727-99-24282. [DOI] [PubMed] [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES